Use Cases for 867 Data in the Age of Product Archetype Diversity

March 19, 2024 at 1:00 PM EST

Manufacturer portfolios are becoming more diversified in terms of product archetypes. Outside of traditional retail brands, traditional syndicated data sources are losing coverage and accuracy as a demand source. 867 data that is carefully stewarded and unblinded can fill enormous gaps for vaccines, specialty lite, specialty HCP admin, bio similars, and specialty generics. In this session, we will discuss different use cases, key stakeholders, and business benefits of enriched 867 data.

Join Emily Mortimer and  Samer Allabadi on March 19 to learn more!

Emily Mortimer
Executive Director, Customer Operations

Samer Allabadi
Senior Director, Channel and Patient Advisory

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article